RecruitingNCT05827159
Emergency-department medication initiation and referral for alcohol use disorder
About this title
Read the official source — NCT05827159Medication studyAges 18–80United StatesAddiction
Understand this study
Who could participate?
Listed age limits: 18 years to 80 years.
- Listed locations
- New HavenSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: August 17, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 240
- Sponsor
- Yale University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Psychotherapy / behavioral intervention, Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 18 Years to 80 Years
- Official registry ID
- NCT05827159
- Official title
Show the full official title
Emergency Department-Initiated Medications for Alcohol Use Disorder
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
New Haven
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Yale University, a university.
Does this study involve medication?
Yes. The study involves medication, including Naltrexone Pill, Naltrexone Injection and Gabapentin Pill.
Who can participate?
Listed age limits: 18 years to 80 years.
Is this study still recruiting?
The registry lists this study as recruiting.
